Episode 730
TWiV 730: COVID-19 clinical update #53 with Dr. Daniel Griffin
March 13, 202144m 35s
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In COVID-19 clinical update #53, Daniel Griffin reviews underreporting of infections and long term disease in children, a blood test for T cells, results of phase 3 trials for monoclonal antibodies, preliminary findings on an oral antiviral, clinical trial of ivermectin, and recommendations for upcoming gatherings.
Hosts: Daniel Griffin and Vincent Racaniello
Subscribe (free): iTunes, Google Podcasts, RSS, email
Become a patron of TWiV!
Links for this episode- SARS-CoV-2 seroprevalence in
- EUA for T cell test (FDA)
- Lilly mAb phase 3 results (Lilly)
- VIR-7831 mAb phase 3 results (Globenewswire)
- Molnupiravir phase 2a results (Merck)
- Ivermectin not supported for mild COVID-19 (JAMA)
- Recommendations for fully vaccinated people (CDC)
- Letters read on TWiV 730
- Timestamps by Jolene. Thanks!
Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to [email protected]